GSK, Sanford Burnham Prebys join forces to discover neuroscience targets

By Shannon EllisStaff Writer SHANGHAI – London-based Glaxosmithkline plc is on the hunt for new ways to treat brain diseases and has found an academic partner in the Sanford Burnham Prebys Medical Discovery Institute (SBP), of La Jolla, Calif. GSK and SBP scientists will work together in a new laboratory to investigate brain function with the aim of identifying and validating new therapeutic targets that can slow down or reverse neurodegeneration. The lab, located in La Jolla, is financially supported for three years with the possibility of an extension by GSK. “If you want to drive progress and test hypotheses that are high risk – but potentially high reward if validated – then you need environments that encourage people to take risks,” Min Li, GSK senior vice president, global head…


Link to Full Article: GSK, Sanford Burnham Prebys join forces to discover neuroscience targets